Cell Line with Stable Expression of Recombinant Human Skeletal Muscle Chloride Channel (hCIC-1)

The invention is a cell line (Human embryonic kidney 293) stably expressing a recombinant human skeletal muscle chloride channel (hClC-1). The cells enable high throughput screening of compounds that modulate chloride channel activity.
Alfred George
Licensing manager: 
Karen Rufus

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter